Integrative Investigation of Lactylome–Proteome Interplay in Diabetic Cardiomyopathy for Pinpointing Disease Development–Associated Pathways or Proteins
Journal of Diabetes Research · 2026-01 · 2026 (1)
DOI: 10.1155/jdr/3543697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 24.04.2026. Verfasst von Di Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China, hrbmu.edu.cn. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Proteome, Protein Processing, Post-Translational, Myocardium. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Project of Ordos, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim Lysine lactylation (Kla) has emerged as a novel posttranslational modification implicated in various disease processes, yet its role in diabetic cardiomyopathy (DCM) pathogenesis remains unknown. The objective of this study was to ascertain whether protein lactylation is involved in DCM progression.
Methods
Proteomic and lactate analysis via liquid chromatography with tandem mass spectrometry was performed on the heart tissues of db/m mice (as the control group) and db/db mice (as the DCM group). Subsequently, a series of bioinformatics analyses was employed to analyze the Kla site and Kla‐modified proteins in the two groups.
Results
Bioinformatics analysis revealed a greater abundance of Kla sites in the DCM group than in the control group. In addition, subcellular localization analysis indicated that Kla‐modified proteins were predominantly located in the cytoplasm and mitochondria. Protein lactylation modification mainly occurred on histone H2, and in comparison to the control group, modification of the H4C1‐K32 site was notably elevated in the DCM group. Furthermore, 113 significantly modified Kla sites were associated with 78 modified proteins in the DCM group, whereas 37 significantly modified Kla sites were associated with 25 modified proteins in the control group. These Kla‐modified proteins participated in biological processes and pathways related to glucose metabolism and DCM. Finally, five candidate sites were identified using random forest, LASSO regression, support vector machine–recursive feature elimination, and logistic regression: A2ASS6_K928_Ttn, A2ASS6_K13499_Ttn, Q61425_K212_Hadh, Q8K2B3_K517_Sdha, and Q9R0Y5_K100_Ak1.
Conclusions
Our findings suggest that protein lactate modification in the lactylome and proteome could be a promising treatment for DCM. This provides a reliable basis for further investigating the roles of Kla and Kla‐modified proteins to develop new and effective therapeutic targets for treating DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China, hrbmu.edu.cn.
- School of Basic Medical Sciences, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China, mdjmu.cn.
- Department of General Surgery, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China, hrbmu.edu.cn.
- Department of Cardiology, Ordos Central Hospital, Ordos, Inner Mongolia Autonomous Region, China.
ORCID-Profile: Wenjie Cai, Hui Yuan, Meixin Shi, Ye Jin, Yifeng Cui, Peng Liu, Xi Liu, Can Wei
Förderung
- Key Research and Development Project of Ordos
- National Natural Science Foundation of China
Zitieren
APA
Ma, D., Cai, W., Yuan, H., Shi, M., Jin, Y., Cui, Y., Liu, P., Liu, X., & Wei, C. (2026). Integrative Investigation of Lactylome–Proteome Interplay in Diabetic Cardiomyopathy for Pinpointing Disease Development–Associated Pathways or Proteins. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/3543697
Vancouver
Ma D, Cai W, Yuan H, Shi M, Jin Y, Cui Y, et al. Integrative Investigation of Lactylome–Proteome Interplay in Diabetic Cardiomyopathy for Pinpointing Disease Development–Associated Pathways or Proteins. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/3543697
BibTeX
@article{Ma2026,
author = {Ma, Di and Cai, Wenjie and Yuan, Hui and Shi, Meixin and Jin, Ye and Cui, Yifeng and Liu, Peng and Liu, Xi and Wei, Can},
title = {Integrative Investigation of Lactylome–Proteome Interplay in Diabetic Cardiomyopathy for Pinpointing Disease Development–Associated Pathways or Proteins},
journal = {Journal of Diabetes Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jdr/3543697}
}
EUVIMED